Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Rural health sign | Image credit: BJP7images - stock.adobe.com
FQHCs Show Low Engagement in Hypertension, Diabetes Trials

April 15th 2025

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

AI representation of housing stability | Image credit: GoldPumaze - stock.adobe.com
Housing Instability Linked to Worse Type 2 Diabetes Outcomes

April 14th 2025

Diabetes concept | Image credit: Sherry Young - stock.adobe.com
GLP-1 RAs, SGLT2 Inhibitors Associated With Reduced MACE, HHF in Patients With Diabetes

April 9th 2025

AJMC
The Role of Advanced Technologies in Improving Diabetes Outcomes

April 7th 2025

Diabetes - Vitalii Vodolazskyi - stock.adobe.com.jpg
More Than 250 Million Individuals Unaware They Have Diabetes

April 7th 2025

More News

April 1 Brings Day One of the Medicare Diabetes Prevention Program, and Challenges for Health Plans
April 1st 2018

April 1 Brings Day One of the Medicare Diabetes Prevention Program, and Challenges for Health Plans

Mary Caffrey
Some Medicare Advantage plans may not be fully ready for the requirements of this history-making preventive service.
Site Logo
April 1st 2018

Guidance That Allows for Higher A1C Misses the Mark

Robert A. Gabbay, MD, PhD, FACP
A commentary from our editor-in-chief on the recent guidance from the American College of Physicians regarding glycemic control for adults with type 2 diabetes.
Site Logo
March 31st 2018

Impact of a Pharmacist-Managed Diabetes Clinic on Quality Measures

Nadia J. Aneese, PharmD Alexandra Halalau, MD Sarah Muench, PharmD Daniel Shelden, DO Janna Fett, PharmD Colleen Lauster, PharmD
This study evaluated a pharmacist-managed diabetes clinic to determine its impact on diabetes-related quality measures.(For Tables and Figures, please access the PDF on last page.)
Site Logo
March 31st 2018

Geographic Access to Endocrinologists for Florida's Publicly Insured Children With Diabetes

Ashby F. Walker, PhD Jaclyn M. Hall, PhD Elizabeth A. Shenkman, PhD Matthew J. Gurka, PhD Heather L. Morris, PhD Michael J. Haller, MD Henry J. Rohrs, MD Kelsey R. Salazar, MPH Desmond A. Schatz, MD
Enrollment, claims, and spatial data are used to demonstrate the importance of outreach strategies for families in rural areas who have children with diabetes. Spatial barriers, alone, do not fully elucidate racial/ethnic disparities in pediatric diabetes for street-level location. (For Tables and the Figure, please access the PDF on the last page.)
Podcast: This Week in Managed Care—Cancer Care for People With HIV and Other Health News
March 31st 2018

Podcast: This Week in Managed Care—Cancer Care for People With HIV and Other Health News

Laura Joszt, MA
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Site Logo
March 31st 2018

Applying Digital Technology in Clinical Trials to Improve Real-World Outcomes

Henry Anhalt, DO
Science 37 hopes to help researchers produce clinical trial results that are closer to real-world experiences, for the benefit of patients, pharma, and payers.
Site Logo
March 31st 2018

How Technology Can Make CMS' Diabetes Prevention Program Viable

Dan Sheeran
Missed sessions are the obvious place where digital programs can find a place in the launch of Medicare's first fully reimbursed preventive service.
Site Logo
March 31st 2018

Mississippi Medicaid Bill Reverses a Trend of Limiting Care, With an Eye Toward Prevention

Mary Caffrey
After taking recommendations from providers, Mississippi lawmakers pass a bill that would end caps on prescription drugs and office visits in Medicaid.
This Week in Managed Care: March 30, 2018
March 30th 2018

This Week in Managed Care: March 30, 2018

This week, the top managed care stories included another insurer announcing it would pass on drug rebates to consumers; FDA approved a new continuous glucose monitor and created a new medical device class; new guidelines address how to treat people with both HIV and cancer.
Site Logo
March 30th 2018

The Potential of a Population Health Strategy to Improve Healthcare Outcomes and Reduce Costs for Medicaid Programs

David J. Dzielak, PhD
With Medicaid consuming a larger share of the Mississippi's budget, innovative solutions were needed to deliver improved health outcomes at a lower cost. A public-private partnership was created to pursued a population health strategy aimed at reducing preterm births and preventing the progression of prediabetes to type 2 diabetes.
Brenda Schmidt Discusses Getting Ready for the Launch of Medicare DPP
March 28th 2018

Brenda Schmidt Discusses Getting Ready for the Launch of Medicare DPP

Brenda Schmidt, CEO of Solera Health, discusses how Solera has been getting ready for the launch of the Medicare Diabetes Prevention Program on April 1, 2018.
FDA Approves Dexcom G6, Streamlines Review for Similar Interoperable CGMs
March 28th 2018

FDA Approves Dexcom G6, Streamlines Review for Similar Interoperable CGMs

Allison Inserro
In a 2-pronged move, the FDA approved the sale of the Dexcom G6 integrated continuous glucose monitoring system for determining blood glucose levels and also classified the unit as a class II medical device, enabling a speedier review for similar future systems.
Site Logo
March 27th 2018

Study Explores Mechanism Linking Statin to Reduced Tumor Size in Endometrial Cancer

Mary Caffrey
The lead researcher said the study could lead to women being given a statin as soon as they are diagnosed with endometrial cancer.
Out-of-Pocket Costs for Insulin Are a Problem. Litigants in Case Disagree on Who Is at Fault
March 23rd 2018

Out-of-Pocket Costs for Insulin Are a Problem. Litigants in Case Disagree on Who Is at Fault

Mary Caffrey
A case filed more than a year ago has taken many turns, landing in a federal court in Trenton, where it has been shaped by a difference of opinion over how to address the role of pharmacy benefit managers (PBMs).
Study Finds Canagliflozin Can Reduce A1C at Lower Cost Than GLP-1 Drugs
March 22nd 2018

Study Finds Canagliflozin Can Reduce A1C at Lower Cost Than GLP-1 Drugs

Mary Caffrey
Adherence may play a role in the real-world findings of the study, which was sponsored by Janssen.
Site Logo
March 19th 2018

Semaglutide Produces Significant, Sustained Weight Loss for Adults With Obesity in Phase 2 Trial

Mary Caffrey
The study compared patients taking semaglutide with those taking placebo and liraglutide, which is approved for treatment of obesity.
Site Logo
March 16th 2018

Introduction to Basal Insulin Therapy: Clinical Management of Diabetes

Jasmine D. Gonzalvo, PharmD, BCPS, BC-ADM, CDE, LDE
Site Logo
March 16th 2018

Evaluating the Managed Care Implications of Longer-Acting Basal Insulin Analog Therapies

Tripp Logan, PharmD Bianca Daisy, PharmD
More Americans Obese, Diabetic, New CDC Report Says
March 15th 2018

More Americans Obese, Diabetic, New CDC Report Says

Allison Inserro
New health statistics from the US government paint a picture of a population that is more obese and more prone to diabetes than it was 20 years ago. On the bright side, however, more people have health insurance.
Site Logo
March 12th 2018

CVD-REAL Results in More Diverse Countries Link SGLT2s to Lower Risk of Death, Heart Attack, Stroke

Mary Caffrey
CVD-REAL, the giant study of real-world evidence comparing sodium glucose co-transporter-2 (SGLT2) inhibitors with other glucose-lowering drugs to treat type 2 diabetes, found a 49% lower risk of all-cause death and a host of other benefits across 6 new, more diverse countries, the study’s lead author told a packed room Sunday at the 67th Scientific Session of the American College of Cardiology in Orlando, Florida.
Site Logo
March 6th 2018

Music Makes a Difference During Cardiac Stress Tests, Study Finds

Mary Caffrey
The study will be presented during the 67th American College of Cardiology Scientific Session in Orlando, Florida.
What We're Reading: Azar to Announce Healthcare Actions; Opposition to CMS Opioid Limits; Diabetes Disagreement
March 6th 2018

What We're Reading: Azar to Announce Healthcare Actions; Opposition to CMS Opioid Limits; Diabetes Disagreement

AJMC Staff
HHS Secretary Alex Azar said the administration will announce actions to lower healthcare costs, as well as a move to give patients control of their data; doctors and patients with chronic pain oppose proposed prescribing limits sought by CMS for opioids; doctor groups are disagreeing about blood sugar targets for patients with diabetes.
Novo Nordisk Announces Phase 3a Trial Results for Oral Semaglutide
February 26th 2018

Novo Nordisk Announces Phase 3a Trial Results for Oral Semaglutide

Samantha DiGrande
On Friday, Novo Nordisk announced the results from PIONEER 1, a phase 3a trial featuring oral semaglutide for treatment of adults with type 2 diabetes (T2D). Oral semaglutide is a new glucagon-like peptide-1 (GLP-1) analogue taken once daily as a tablet, making this investigational therapy the first oral treatment in this class.
Early Look at ACC Navigator Program Shows Inpatient Mortality Drops as Hospitals Take Positive Steps
February 26th 2018

Early Look at ACC Navigator Program Shows Inpatient Mortality Drops as Hospitals Take Positive Steps

Mary Caffrey
In the next phase of the program, researchers will dig into the data they have gathered so far to identify the best practices for reducing 30- and 90-day readmission rates.
Brenda Schmidt Discusses Educating People on Their Type 2 Diabetes Risk
February 22nd 2018

Brenda Schmidt Discusses Educating People on Their Type 2 Diabetes Risk

There is a lot of energy around educating consumers about their risk for type 2 diabetes, explained Brenda Schmidt, CEO of Solera Health.
Podcast: This Week in Managed Care—Rising Healthcare Spending and Other Health News
February 17th 2018

Podcast: This Week in Managed Care—Rising Healthcare Spending and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: February 16, 2018
February 16th 2018

This Week in Managed Care: February 16, 2018

This week, the top managed care stories included a report from CMS that found healthcare spending will rise 5.5% over the next 8 years; the budget deal passed by Congress included a number of provisions with long-term health impact; a study found eating a low-carb could help reverse type 2 diabetes.
Site Logo
February 16th 2018

Leveraging Benefit Design for Better Diabetes Self-Management and A1C Control

Abiy Agiro, PhD Yiqiong Xie, PhD Kevin Bowman, MD Andrea DeVries, PhD
Patients with diabetes receiving insulin treatment with lower cost sharing for blood glucose testing strips were more likely to achieve glycemic control than those with higher cost sharing.
Roche Acquires Flatiron Health for $1.9 Billion
February 16th 2018

Roche Acquires Flatiron Health for $1.9 Billion

Mary Caffrey
Flatiron Health expects to maintain its current business model in the transaction.
In Real-World Study, Toujeo Reduced Risks of Severe Hypoglycemia Compared With Older Insulins
February 15th 2018

In Real-World Study, Toujeo Reduced Risks of Severe Hypoglycemia Compared With Older Insulins

Mary Caffrey
The study used a claims database to examine records from patients who switched between long-acting insulins.
<1
...
272829303132333435
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo